William J. Peters - 16 Mar 2022 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
CFO, EVP & Treasurer
Signature
/s/ William J. Peters
Issuer symbol
AMPH
Transactions as of
16 Mar 2022
Net transactions value
-$1,306,425
Form type
4
Filing time
18 Mar 2022, 18:57:57 UTC
Previous filing
17 Mar 2022
Next filing
20 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $731,189 +50,777 +44% $14.40 164,921 16 Mar 2022 Direct
transaction AMPH Common Stock Sale $1,595,230 -47,017 -29% $33.93 117,904 16 Mar 2022 Direct F1
transaction AMPH Common Stock Sale $129,197 -3,760 -3.2% $34.36 114,144 16 Mar 2022 Direct F2
transaction AMPH Common Stock Tax liability $170,929 -4,995 -4.4% $34.22 109,149 16 Mar 2022 Direct F3
transaction AMPH Common Stock Tax liability $142,257 -4,162 -3.8% $34.18 104,987 17 Mar 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -50,777 -100% $0.000000* 0 16 Mar 2022 Common Stock 50,777 $14.40 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.24 to $34.235, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.24 to $34.66, inclusive.
F3 The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.
F4 Shares subject to the option are fully vested and immediately exercisable.